Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Pediatr Crit Care Med. 2017 Jun;18(6):561–570. doi: 10.1097/PCC.0000000000001155

Table 5.

Multivariable Model for Pediatric Cohort

Characteristic Outcome
Mortality
FSSa (among survivors)
Adjusted Relative Riskb (95% CI) P-value Adjusted Effectc (95% CI) P-value
Indication for ECMOd <.01
 Respiratory --- ---- Reference
 Cardiac --- --- −0.89 (−1.85, 0.07)
 ECPRe --- --- 1.41 (−0.09, 2.91)
Neurologic chronic diagnosis 1.82 (0.31, 3.33) 0.02
Chronic cardiovascular diagnosis 1.33 (1.06, 1.67) 0.01 ---
Other chronic diagnosis --- --- 1.11 (0.04, 2.18) 0.04
Hepatic organ dysfunction 1.39 (1.09, 1.76) <.01 2.03 (0.96, 3.10) <.01
Baseline ventilator or tracheostomy --- --- 11.67 (8.01, 15.33) <.01
ICU LOS (weeks)f --- --- 0.08 (0.03, 0.13) <.01
Neurologic event 1.82 (1.39, 2.37) <.01 --- ---
Thrombotic event 1.43 (1.13, 1.80) <.01 --- ---
Achieved lactate < 2 mmol/L 0.54 (0.43, 0.68) <.01 --- ---
a

FSS is Functional Status Score;

b

Mortality was modeled using Poisson regression with robust error estimates;

c

FSS among survivors was modeled using standard linear regression;

d

ECMO is extracorporeal membrane oxygenation;

e

ECPR is extracorporeal cardiopulmonary resuscitation;

f

LOS is length of stay